A method is described in which anti-2-acetylaminofluorene immunoglobulins may be detected using a simple and sensitive screening procedure. The method is based on immunoglobulin binding of an 1251 derivatized 2-aminofluorene radiotracer. Tracer binding is not isotype specific, and thus the method is useful for the detection of either IgG or IgA. Competitive binding experiments with the radiotracer were used to determine the specificity of immunoglobulin response by measurement of cross-reactivity with related ligands. This method allows quantitation of the immune response to the carcinogen in serum and other biological fluids (i.e., intestinal secretions).
Introduction
2-Acetylaminofluorene (2-AAF) is a wellstudied model compound for the investigation of arylamine/arylacetamide carcinogenesis in several animal species. Upon absorption, the parent compound becomes a substrate for a variety of metaboric enzymes, some of which detoxify the compound, while others produce reactive chemical intermediates substantially more toxic to the organism than the parent compound (Miller et al., 1960; Miller and Miller, 1964) . N-hydroxylation of 2-AAF to the arylhydroxamic acid (Miller et al., 1960; Frederick et al., 1982) and subsequent phase 2 conjugation via sulfation (DeBaun et al., 1968; Meerman et al., 1981; Lai et al., 1985 Lai et al., , 1987 , glucuronidation (Sakai et al., 1978) , N,O-acyltransfer (Weeks et al., 1978), or O-acetylation (Flamang and Kadlubar, 1986) can result in the formation of electrophilic intermediates capable of damaging cellular macromolecules. The formation of DNA adducts which result from the reaction of electrophilic 2-AAF metabolites with nucleophilic centers in the DNA helix, have been postulated to serve as a committed initiation step in the neoplastic transformation of cells (Garner et al., 1984; Miller and Miller, 1981) .
Several investigators have attempted to prevent the sequence of metabolic events leading to DNA damage by immobilizing the parent carcinogen immunologically prior to activation and toxicity Franks and Creech, 1939; Peck and Peck, 1971; Tompa et al., 1979; Moolton et al., 1981) . Using parenteral immunization, these studies have demonstrated the ability to produce a systemic humoral immunity (IgG) to several carcinogens. Although some studies have shown that the presence of this humoral immunity correlated with an inhibition of chemically induced neoplasia, others have shown an increase in tumorigenesis following immunization Curtis et al., 1978) . suggested that the development of a mucosal immunity (IgA) to 7,12-dimethylbenz(a)athracene (DMBA) and related PAH carcinogens could facilitate excretion of the carcinogen by preventing absorption into the body. Mice immunized with an intraperitoneal, followed by an intragastric dose of a fluorinated derivative of DMBA-BSA conjugate showed increased levels of [3H]benzo(a)pyrene binding in the ~,-globulin fraction of fecal extracts following ingestion of the radiolabelled carcinogen. However, no direct determination of the presence of IgA-anti-PAH was made in these studies.
Recent studies in our laboratory aimed at stimulating a mucosal immune response against 2-AAF ( Keren et al., 1987) have created a need for a simple, sensitive method for screening large numbers of biological fluids for anti-AAF immunoglobulins. In the present report we describe the synthesis of a radiotracer bearing the aminofluorene hapten covalently coupled to p-hydroxyphenylacetic acid, which is subsequently iodinated with Na125I. Binding of this radiotracer serves as the basis of a sensitive immunoassay for the detection of anti-AAF immunoglobulins. Cross-reactivity studies using this radiotracer have provided information on the specificity of the immunoglobulin response to AAF-protein conjugates.
Competitive microELISA experiments have confirmed the presence of IgG anti-AAF immunoglobulins in sera from immunized rats and rabbits testing positive by the 1251 binding assay described. Similarly, IgA-anti-AAF immunoglobulins have been detected in rabbit intestinal secretions following immunization with AAF-carrier protein conjugates using this method (Keren et al., 1987) .
Materials and methods
Succinic anhydride, 2-acetylaminofluorene (2-AAF), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide-HC1 (EDAC), bovine serum albumin, ovalbumin, thyroglobulin, p-nitrophenyl phosphate, and fluorene were obtained from Sigma Chemical Co. (St. Louis, MO). Anthracene, 2-aminofluorene (2-AF), 2-nitrofluorene, 9-aminofluorene-HC1, carbazole, biphenyl, 1-aminofluorene, 2-aminoanthracene, 3-aminofluoranthene, and 3-amino-9-ethylcarbazole were obtained from Aldrich Chemical Co. (Milwaukee, WI). New Zealand White rabbits were purchased from Langshaw, Sprague-Dawley rats were purchased from Charles River, ELISA microtiter plates were obtained from Dynatech, Tween 20 was purchased from Baker Chemical Co., and goat anti-rat IgG (GARTG) was purchased from Cappel. All other buffers, solvents and reagents were analytical grade or better.
Melting points were determined with a Thomas Hoover capillary melting point apparatus and are uncorrected. The Ig spectra were recorded on a Perkin Elmer 281 spectrophotometer and values are expressed in cm 1. The 1H nmr spectra were obtained on a Bruker WP270SY (270 MHz) spectrophotometer. The chemical shift values are reported in parts per million on the 8 scale with tetramethylsilane as the internal reference. The microanalyses were performed by M-H-W Laboratories, Phoenix, AZ. The thin layer chromatography (TLC) was performed on silica gel-GF (Analtech) plates. The detection of compounds on TLC was made using UV light. The evaporation of solvents was carried out under reduced pressure with a rotary evaporator using a water aspirator at the temperature noted.
Synthesis of the 1251 radiolabel N-2-(4-acetoxyphenylacetamido)fluorene [2].
The synthetic method used to prepared the a25I radiolabel is summarized in Fig. 1 . The synthesis of the p-hydroxyphenylacetic anhydride [1] was accomplished using the method of Nordblom et al. (1981) * 2-Aminofluorene (1.2 g, 6.62 mmol) was dissolved in dry pyridine (100 ml). p-Acetoxyphenylacetic anhydride (3.85 g, 10.4 mmol) was then added and the mixture was heated at reflux for 1 * The yield of anhydride can be greatly increased by omission of the NaHCO 3 wash step described.
h. When complete, the mixture was acidified with 1 N HC1 and extracted with methylene chloride (4 × 200 ml). The combined organic layer was washed successively with 100 ml portions of H2 O, 1 M NaHCO 3, H20, 1 N HC1 and H20. The methylene chloride was dried over MgSO 4, filtered, and the solvent removed in vacuo. The resulting residue was dissolved in a minimum quantity of hot toluene, filtered through a Celite/decolorizing charcoal filter cake and allowed to crystallize. Collection of the solid yielded 0.84 g of N-2-(4-acetoxyphenylacetamido)fluorene ( 
N-2-(4-hydroxyphenylacetamido)fluorene [3].
N-2-(4-Acetoxyphenylacetamido)fluorene [2] (200 mg, 0.56 mmol) was dissolved in dry methanol (50 ml), and sodium methoxide (10 /zg) was added.
The solution was heated to 40 °C and stirred for 4 h. After allowing the mixture to cool to room temperature, the methanol was removed in vacuo and the remaining solid was suspended in H20 (500 nal). The pH was adjusted to 2 with 1 N HC1. The aqueous suspension was extracted with methylene chloride (4 × 200 ml). The combined organic extract was washed twice with H20 and dried over MgSO 4. The mixture was filtered and the solvent was evaporated in vacuo. The resulting solid was recrystallized from hot toluene to yield 100 mg of N-2-(4-hydroxyphenylacetamido) 
Radioiodination of pHP-AAF [4],[5]
N-2-(4-hydroxyphenylacetamido) fluorene [3] (10 mg, 0.03 mmol) was dissolved in methanol (10 ml). To 2.0/~1 (6.3 nmol) of this solution in a 0.5 (Fig. 2) . The solvent flow rate was held constant at 1 ml/min throughout the elution, and 2 ml fractions were collected for the first 30 min of the elution, followed by 1 ml fractions for the remainder of the elution. The radioactivity in each fraction was counted using an Eberline Mini-Scaler (MS-2) fitted with a 6 in tube such that the external geometry would only allow a small portion of the radioactivity to be registered (0.0022%), permitting identification of the active fractions without dilution.
The specific radioactivity of the monoiodinated tracer was determined using the method of Morris (1976) , which compares the amount of bound vs. free radiolabel in parallel incubations with either doubling dilutions of iodinated tracer ('hot'), or doubling dilutions of the 'cold' carrier molecule (the pHP-AAF), each in the presence of a small but constant quantity of radiotracer and antibody. For the radiolabelled self-displacement curve, approximately doubling dilutions of isotope (presumed to be the monoiodinated radiotracer) were dispensed ranging from 5000 to 570000 cpm. A constant quantity of radiolabel was added to each tube (11 000 cpm), and the self-displacement competition was initiated with the addition of 100 /~1 of a 1 : 50 000 dilution of AF-60 rabbit anti-serum. The cold self-displacement curve was set-up in a similar fashion, only cold carrier compound (pHP-AAF) was added in a masses ranging from 10 pmol to 1000 pmol. An identical mass of radioisotope was added to these tubes as in the 'hot' displacement samples above (11000 cpm), as well as the addition of the antiserum. Both sets of samples were allowed to equilibrate for 2 h at room temperature, followed by the separation of bound counts from free with the addition of 1.0 ml dextran coated charcoal (kept at 4°C). The tubes were immediately centrifuged at 2400 rpm for 5 rain. The clear supernatants (containing antibody bound counts) were transferred to clean tubes and counted in the Hydrogamma-16 gamma counter. The ratios of bound versus free counts were calculated for both sets of samples, and the amount of cold mass required to displace a known quantity of iodinated label was obtained. The specific activity of the radiotracer was determined graphically as described by Morris (1976) .
N-2-Fluorenylsuccinamic acid (SAF)
2-Aminofluorene (5.0 g, 28 mmol) was dissolved in dry pyridine (150 ml) under a nitrogen atmosphere. Succinic anhydride (7.5 g, 75 mmol) was added slowly with gentle stirring. The reaction was allowed to stand in the dark at room temperature with stirring for 14 h. The pyridine was removed in vacuo using a roto-evaporator and a dry ice trap. The resulting solid was recrystallized from absolute ethanol to yield 4.52 g of tan needles (57% yield, MP=225-227°C with decomposition). IR (KBr pellet) Vm~x, 3305, 1695 Vm~x, 3305, , 1650 Vm~x, 3305, , 1590 Vm~x, 3305, , 1510 Vm~x, 3305, , 1420 Fig. 3 illustrates the conditions of the conjugation reaction used to couple SAF to a variety of carrier proteins. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide-HC1 (EDAC, 45 mg, 0.23 mmol) was dissolved in 1 ml of 0.05 M 2-(Nmorpholino)ethanesulfonic acid (MES) buffer, pH 4.75. This solution was added dropwise with stirring to a solution of 66 mg (0.23 mmol) SAF dissolved in 9 ml of dimethylformamide (DMF) 107 and allowed to stand for 1 h at room temperature with stirring. The cartier protein was dissolved in 0.05 M cyclohexylaminoethane sulfonic acid buffer (CHES), pH 9.5 (0.42 #mol carrier protein dissolved in 42 ml CHES buffer). The SAF solution was then added dropwise to the carrier protein solution with gentle stirring and allowed to stand for 14 h. The solution was transferred to dialysis tubing and dialyzed against 4-5 one liter changes of phosphate-buffered saline (PBS) until the absorbance of the dialysate attained an absorbance less than 0.010 at 280 nm. The retentate (with the exception of thyroglobulin conjugates) was filtered through a 0.45 /~m filter and stored in 1.5 ml aliquots at -20 o C.
Optimization of conjugation conditions
The degree of SAF substitution per mole of carrier protein was estimated in the following manner. The protein concentration of the conjugated solution was determined by Coomassie blue dye binding assay (Bradford, 1976) and the absorbance of the conjugate solution was measured at 280 nm. The absorbance of the carrier protein alone at a comparable concentration was estimated from a standard curve and subtracted from the latter value. The molar extinction coefficient of SAF at 280 nm was determined to be 20056 M-1 cm-a by serial PBS dilutions at neutral pH from a 1 mg/ml stock solution of SAF in dimethylformamide. The residual absorbance after subtraction of the protein absorbance was presumably due to SAF and was converted to molar equivalents. The molar ratio of SAF to protein estimated by this method routinely fell in the range of 20-30 for albumin carrier proteins.
Immunization and antibody response
Four rabbits were given multiple-site intramuscular injections containing a total of 200-400/~g SAF-carrier protein conjugate in 1-2 ml 50 : 50 complete Freund's adjuvant (CFA, PBS, v/v). SAF-carrier protein conjugate (100 /~g in 1.0-1.8 ml 50:50 complete Freund's adjuvant) were given to three rats, sub-cutaneously over the hips. Similar booster immunizations were given 16 days later. Blood samples were collected weekly and tested for the capacity to bind the radiotracer in serial dilutions. Certain animals were given a second boost with the original conjugate, while others received SAF attached to a different carrier protein.
The specificity of the antibody was determined by equilibrium competition experiments involving related chemical compounds. Each competing ligand was incubated in the presence of constant quantities of iodinated tracer (50000 cpm) and antibody (AF-60 antiserum, 1:100000 dilution). Increasing amounts of each competing ligand were added to determine the mass at which 50% inhibition of the radiolabel binding occurred (I50). The percent cross-reactivity was calculated relative to the I50 of the non-iodinated tracer (pHP-AAF).
Competitive microELISA
Competitive microELISA studies were performed in parallel with the IBA as an independent confirmation of the ability to detect anti-AAF immunoglobulins. Microtiter wells were coated overnight with 100 /~1 of 20 /~g/ml SAF-protein conjugates at 4°C dissolved in 0.05 M bicarbonate buffer, 1 mM MgC12, pH 9.6. Test antiserum was run in wells coated with a SAFprotein conjugate containing an unrelated carrier protein to reduce non-hapten-specific protein binding. Carrier protein control wells were run in parallel experiments and subtracted as a background value from the total binding value. Antisera dilutions ranged from 1 : 50 to 1 : 200 for rat antisera and were 1:20 for rabbit antisera with the exception of rabbit AF-60 which was diluted 1:20000.
For inhibition studies, increasing amounts of free 2-AAF were pre-incubated with the antisera for 1 h prior to its addition to the conjugate-containing well. The 2-AAF was diluted from a stock solution of 1 mg/ml in DMF. The 1000 ng 2-AAF competition values were performed at 1% DMF. All other experimental tubes were adjusted to contain 0.1% DMF in PBS (v/v). The antigen-antibody binding was not effected at DMF concentrations of 1% or less (data not shown). These mixtures were then added to the microtiter wells and incubated at room temperature for 4 h. The plates were then washed with several volumes of PBS containing 0.05% Tween 20 (PT), followed by the addition of alkaline phosphatase-conjugated sheep anti-rabbit IgG (100/~1, isotype specific, affinity column purified using methods previously described) (Keren, 1979) to each well. For the rat antiserum studies, alkaline phosphatase-conjugated goat anti-rat IgG was used. After an overnight incubation, the wells were washed with PT, blotted dry, and the substrate reaction was carried out with the addition of 100 #1 of p-nitrophenyl phosphate (1 mg/ml stock solution) dissolved in substrate buffer (0.05 M Na2CO3/NaHCO 3, 1.0 mM, MgC12, pH 9.8). The absorbance of each well was measured at 12.5, 25, 50 and 100 min on a Titertek microELISA reader using the 405 nm filter. If the 100 min reading exceeded the linearity of the instrument (Abs. > 2.0), the 100 min measurement was extrapolated from the next earliest reading. Percent inhibition was calculated from the mean of two wells containing 0-1000 ng 2-AAF based on similar wells containing no 2-AAF.
Results
The reaction mixture produced from radioiodination of the pHP-AAF tracer molecule was applied to a C-18 reverse-phase HPLC column as described in the materials and methods section.
The elution profile shown in Fig. 2 contained three major peaks. Peak A contained 83% of the total radioactivity applied to the column as free 1251 anion. Peak B, which eluted in fractions 39-41 (69-71 min time of elution) contained the monoiodinated radiotracer, with 5.8% of the total radioactivity. Peak C eluted in fractions 51-53 (81-83 min time to elution) and contained the diiodinated radiotracer molecule with 13.6% of the total activity.
The specific activity of the compound isolated in fraction 39-41 (the monoiodinated species) was calculated using the method of Morris (1976) to be 1900 Ci/mmol (following correction for counting efficiency and decay from the date of iodination). This is in close agreement with the maximum theoretical yield of 2180 Ci/mmol.
Sera from rats and rabbits immunized with SAF-protein conjugates were screened for the ability to bind the 125I tracer. Sera from two of three rats, and from six of ten rabbits, bound greater than 40% of the iodinated label at a 1 : 1000 serum dilution. Fig. 4 shows the complete titration curve of antisera from rabbit AF-60 at log dilutions 109 from 1:10 to 1:1000000. Significant binding of the tracer molecule was detected at dilutions as high as 1 : 1 000 000. Similar dilutions of non-immune rabbit serum bound consistently less than 2% of the tracer. A 1 : 100 000 dilution was chosen for the antibody specificity studies.
Data presented in Table I clearly indicates a high degree of specificity toward ligands containing a -N-CO-CH 2-at the 2 position of the fluorene ring. The antibody showed less affinity toward arylamines (2-aminofluorene, 2-aminoanthracene, 1-aminoanthracene, and 9-aminofluorene) than for arylacetamides, and the specificity toward the ring structures alone was slightly less than for the corresponding arylamines. Surprisingly, the antibody specificity was higher toward 2-aminoanthracene and anthracene than for 2-aminofluorene and fluorene, respectively. Less related compounds had correspondingly higher crossreactivity values, (two and four membered ring systems and ring systems with bulky side chains, e.g., 3-amino-l-ethylcarbazole). Following a 2 h equilibration period at room temperature, the bound and free counts were separated using dextran-coated charcoal, and the radioactivity was quantitated using a Hydrogamma-16 gamma counter. Cross-reactivity values were calculated based on a value of 1 for the non-iodinated carrier molecule (pHP-AAF). Since the hapten (2-AAF) could not be adsorbed to the microtiter plates, carrier protein-SAF conjugates were used. The highest titer rabbit (open rectangles) and rat antisera (shaded rectangles) were incubated for 1 h with the designated concentration (10 ng/well = 100 ng/ml in the incubation system) of 2-AAF. The antiserum-AAF mixtures were then added to the microtiter plate and incubated for 4 h at room temperature. The plates were washed three times with copious quantities of PT, and the appropriate second antibody conjugated to alkaline phosphatase was added (either sheep anti-rabbit IgG or goat anti-rat IgG). The absorbance at 405 nm was measured, and the percent inhibition was calculated from similar incubations containing no 2-AAF. Values expressed are the mean of two observations.
Cross
in the presence of increasing concentrations of 2-AAF. The inhibition of binding was clearly concentration dependent and nearly 100% efficient at high 2-AAF concentrations (1 #g/well for all rats tested). Rabbit AF-60 antiserum binding was inhibited 68% at the lowest concentration tested (1 ng/well) and was over 90% inhibited at a concentration of 10 ng/well. Other rabbits in the series tested were not as sensitive to 2-AAF inhibition, ranging from 6 to 38% inhibition at 1 ng/well.
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Discussion
The detection of antibodies directed against 2-AAF is of critical importance in recent studies on the mucosal immune response to 2-AAF-carrier protein conjugates conducted in our laboratory (Keren et al., 1987) . A rapid, sensitive, hapten-specific method which could be applied to a large number of specimens was required. The immunoglobulin binding method based on an 125I-radiotracer was developed to meet this need. The 2-AAF binding assay described in this study was capable of detecting antibodies to 2-AAF at serum dilutions as high as 1 : 1 000 000. The presence of anti-AAF immunoglobulin in antisera from immunized rats and rabbits testing positive by the immunoglobulin binding assay was confirmed by competitive microELISA. Increasing 2-AAF concentrations caused dose-dependent inhibition of immunoglobulin binding to SAF-protein conjugates. This inhibition was nearly 100% effective at a 2-AAF concentration of 1 /~g/well for both rat and rabbit antiserum.
The 1251 radiotracer also allowed an examination of the antibody specificity by performing cross-reactivity studies. These studies indicated that the polyclonal antibody response was directed primarily against the entire fluorenylacetamide group. Related compounds with ring substitutions or lacking the acetamide group were less able to compete with the tracer for the antibody binding sites.
This method has proven very useful in the screening of both antiserum and intestinal secretions (Keren et al., 1987) from immunized rats and rabbits. Although not isotype specific, it provides a simple, fast and sensitive screening assay for the detection of anti-AAF immunoglobulins in biological fluids.
